Taiwan FDA registration ce0ee7c9382a13623ced5633a58df69a

"Abe" insulin injection pen special needle (safety type)

TW: “安倍”胰島素注射筆專用針(安全型)

Taiwan·Risk Class 2·PROMISEMED HANGZHOU MEDITECH CO., LTD.·Registered Dec 28, 2022 – Dec 28, 2027Active

Registration details

Analysis ID: ce0ee7c9382a13623ced5633a58df69a
Customs Code: DHA09200140705

Company information

Manufacturer: PROMISEMED HANGZHOU MEDITECH CO., LTD.
Manufacturer Country: China
Authorized Representative: WINE-FONT INTERNATIONAL COMMERCE CORP.

Product details

Intended Use: Details are as detailed as approved Chinese instructions
Product Type (Level 1): J General hospital and personal use equipment
Product Type (Level 2): J.5570 Subcutaneous single-chamber needle
Import Information: Input;; Chinese goods

Dates and status

Registration Date: Dec 28, 2022
Expiry Date: Dec 28, 2027

About this record

Access comprehensive regulatory information for "Abe" insulin injection pen special needle (safety type) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ce0ee7c9382a13623ced5633a58df69a and manufactured by PROMISEMED HANGZHOU MEDITECH CO., LTD.. The authorized representative in Taiwan is WINE-FONT INTERNATIONAL COMMERCE CORP..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.